ML246
ML246 Basic information
- Product Name:
- ML246
- Synonyms:
-
- ML246
- Metarrestin (ML246)
- Cyclohexanol, 4-[4,7-dihydro-4-imino-5,6-diphenyl-7-(phenylmethyl)-3H-pyrrolo[2,3-d]pyrimidin-3-yl]-, trans-
- trans-4-(7-benzyl-4-imino-5,6-diphenylpyrrolo[2,3-d]pyrimidin-3-yl)cyclohexan-1-ol
- ML-246,breast,perinucleolar,HeLa,Metarrestin,nucleolar,Inhibitor,DNA/RNA Synthesis,PANC1,orally,metastatic,transcription,inhibit,eEF1A2,PC3M,compartment,pancreatic,ML 246
- trans-4-(7-Benzyl-4-imino-5,6-diphenyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)cyclohexan-1-ol
- Metarrestin, 10 mM in DMSO
- Metarrestin (ML246) ,S3472
- CAS:
- 1443414-10-5
- MF:
- C31H30N4O
- MW:
- 474.6
- Mol File:
- 1443414-10-5.mol
More
Less
ML246 Chemical Properties
- Boiling point:
- 651.7±65.0 °C(Predicted)
- Density
- 1.24±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: 31.25 mg/mL (65.84 mM)
- form
- Solid
- pka
- 14.93±0.40(Predicted)
- color
- White to off-white
More
Less
ML246 Usage And Synthesis
Uses
ML246 is a perinucleolar compartment (PNC) modulator/ Inhibitor.
in vivo
Metarrestin (ML246; 5-25 mg/kg; IP; once daily; continuing for six weeks) displays a decrease in metastatic burden in both liver (p <0.01) and lung with 25 mg/kg[2].
?
Metarrestin (drug-infused chow; 10 mg/kg; 70 ppm) extends survival in the NSG PANC1 pancreatic cancer metastasis mice model[2].
?
Metarrestin (5, 25 mg/kg; ip; for 4 additional week) reduces metastasis of prostate cancer (PC3M) and growth of metastatic breast cancer PDX mice models[2].
?
Metarrestin (5 and 25 mg/kg; IP) has a half-life of 4.6 to 5.5 hours[2].
| Animal Model: | NOD/IL2 gamma (null) PANC1 mice over primary tumor tissues[2] |
| Dosage: | 5 and 25 mg/kg |
| Administration: | IP; once daily; continuing for six weeks |
| Result: | Displayed a decrease in metastatic burden in both liver (p <0.01) and lung with 25 mg/kg. Demonstrated a significant reduction of perinucleolar compartment prevalence in metastatic and primary tumor tissues. |
| Animal Model: | Female BALB/c mice[2] |
| Dosage: | 5 and 25 mg/kg (Pharmacokinetic Analysis) |
| Administration: | IP |
| Result: | Indicated good exposure, distribution, and tolerability in vivo, with a half-life of 4.6 to 5.5 hours. |
ML246Supplier
Shanghai Lollane Biological Technology Co.,Ltd.
- Tel
- 021-52996696,15000506266 15000506266
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Shanghai Rechem science Co., Ltd.
- Tel
- 021-31433387 15618786686
- sales@rechemscience.com
More
Less
ML246(1443414-10-5)Related Product Information
- 5-[(4-Nitrobenzoyl)oxy]-2-[(2-pyrimidinylthio)methyl]-4H-pyran-4-one
- ML-228
- ML188 (Racemate)
- ML 18
- ML-098
- ML277
- ML 204
- ML329
- ML364
- VU0456810
- ML188
- ML418
- [4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone
- ML213
- N-(3,4-difluorophenyl)-2-pyridin-4-ylquinazolin-4-amine
- ML-327
- PTP1B-IN-2
- ML264